Search research articles
Contact Us
Filters
Showing results (1071-1080 of 1,158) with videos related to
Page
of 116
Sort By:
JAMA Cardiology
|
August 24, 2022
Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial
Nicolas M Van Mieghem, G Michael Deeb, Lars Søndergaard, et al.
JAMA Cardiology
|
June 29, 2017
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration
Gennaro Giustino, Rafael Harari, Usman Baber, et al.
The New England Journal of Medicine
|
August 28, 2018
One-Year Outcomes after PCI Strategies in Cardiogenic Shock
Holger Thiele, Ibrahim Akin, Marcus Sandri, et al.
The Annals of Thoracic Surgery
|
October 7, 2023
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
Rebecca T Hahn, Matthew K Lawlor, Charles J Davidson, et al.
JACC. Cardiovascular Interventions
|
October 7, 2023
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI
Marco Valgimigli, Alessandro Spirito, Samantha Sartori, et al.
JACC. Cardiovascular Interventions
|
September 24, 2016
Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration
Gennaro Giustino, Ioannis Mastoris, Usman Baber, et al.
Journal of the American College of Cardiology
|
October 7, 2023
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
Rebecca T Hahn, Matthew K Lawlor, Charles J Davidson, et al.
European Heart Journal
|
October 4, 2023
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
Rebecca T Hahn, Matthew K Lawlor, Charles J Davidson, et al.
American Heart Journal
|
February 1, 2019
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study
Enrico Frigoli, Pieter Smits, Pascal Vranckx, et al.
Circulation. Cardiovascular Interventions
|
July 11, 2019
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents
Usman Baber, Giulio G Stefanini, Gennaro Giustino, et al.
Page
of 116
Search research articles
Search
Showing results (1071-1080 of 1,158) with videos related to
Sort By:
Page
of 116
JAMA Cardiology
|
August 24, 2022
Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial
Nicolas M Van Mieghem, G Michael Deeb, Lars Søndergaard, et al.
JAMA Cardiology
|
June 29, 2017
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration
Gennaro Giustino, Rafael Harari, Usman Baber, et al.
The New England Journal of Medicine
|
August 28, 2018
One-Year Outcomes after PCI Strategies in Cardiogenic Shock
Holger Thiele, Ibrahim Akin, Marcus Sandri, et al.
The Annals of Thoracic Surgery
|
October 7, 2023
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
Rebecca T Hahn, Matthew K Lawlor, Charles J Davidson, et al.
JACC. Cardiovascular Interventions
|
October 7, 2023
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI
Marco Valgimigli, Alessandro Spirito, Samantha Sartori, et al.
JACC. Cardiovascular Interventions
|
September 24, 2016
Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration
Gennaro Giustino, Ioannis Mastoris, Usman Baber, et al.
Journal of the American College of Cardiology
|
October 7, 2023
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
Rebecca T Hahn, Matthew K Lawlor, Charles J Davidson, et al.
European Heart Journal
|
October 4, 2023
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
Rebecca T Hahn, Matthew K Lawlor, Charles J Davidson, et al.
American Heart Journal
|
February 1, 2019
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study
Enrico Frigoli, Pieter Smits, Pascal Vranckx, et al.
Circulation. Cardiovascular Interventions
|
July 11, 2019
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents
Usman Baber, Giulio G Stefanini, Gennaro Giustino, et al.
Page
of 116